Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: A quantitative and kinetic study

European Heart Journal Cardiovascular Imaging

Volumn 17, Issue 1, 2016, Pages 76-84

  Hammer Hansen, Sophia ^a,b   Patricia Bandettini, W ^a   Hsu, Li Yueh ^a   Leung, Steve W ^a,c   Shanbhag, Sujata ^a   Mancini, Christine ^a   Greve, Anders M ^a   Køber, Lars ^b   Thune, Jens Jakob ^b   Kellman, Peter ^a   Arai, Andrew E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Acute myocardial infarction; Cardiovascular magnetic resonance imaging; Extracellular volume; Gadolinium enhancement; Gadolinium kinetics

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; TROPONIN; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; EXTRACELLULAR SPACE; FEMALE; HEART CATHETERIZATION; HEART INFARCTION SIZE; HEART MUSCLE; HUMAN; KINETIC PARAMETERS; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE STUDY; REPERFUSION; AGED; CINE MAGNETIC RESONANCE IMAGING; CLASSIFICATION; IMAGE ENHANCEMENT; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

AGED; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84960355352     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jev123     Document Type: Article

References (32)

1. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
2. Hsu LY, Natanzon A, Kellman P, Hirsch GA, Aletras AH, Arai AE. Quantitative myo-cardial infarction on delayed enhancement MRI. Part I: animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006;23:298-308.
3. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004;43:2253-9.
4. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-7.
5. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733-43.
6. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA 2012;308:890-6.
7. Di Bella G, Siciliano V, Aquaro GD, Molinaro S, Lombardi M, Carerj S et al. Scar extent, left ventricular end-diastolic volume, and wall motion abnormalities identify high-risk patients with previous myocardial infarction: a multiparametric approach for prognostic stratification. Eur Heart J 2013;34:104-11.
8. Beek AM, Kuhl HP, Bondarenko O, Twisk JW, Hofman MB, van Dockum WG et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003;42:895-901.
9. El Aidi H, Adams A, Moons KG, Den Ruijter HM, Mali WP, Doevendans PA et al. Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies. J Am Coll Cardiol 2014;63: 1031-45.
10. Fieno DS, Hillenbrand HB, Rehwald WG, Harris KR, Decker RS, Parker MA et al. Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctionsofvarying size. J Am Coll Cardiol 2004;43: 2124-31.
11. Dall'Armellina E, Karia N, Lindsay AC, Karamitsos TD, Ferreira V, Robson MD et al. Dynamic changesofedema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ Cardi-ovasc Imaging 2011;4:228-36.
12. Mather AN, Fairbairn TA, Artis NJ, Greenwood JP, Plein S. Timing of cardiovascular MR imaging afteracute myocardial infarction: effectonestimatesofinfarct characteristics and prediction of late ventricular remodeling. Radiology 2011;261:116-26.
13. Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann H, Higgins CB. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 2001;103:871-6.
14. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001;104:2838-42.
15. Matsumoto H, Matsuda T, Miyamoto K, Shimada T, Mikuri M, Hiraoka Y. Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction. JACC Cardiovasc Imaging 2011;4:610-8.
16. Matsumoto H, Matsuda T, Miyamoto K, Shimada T, Ushimaru S, Mikuri M et al. Temporal changeofenhancement after gadolinium injection on contrast-enhanced CMR in reperfused acute myocardial infarction. J Cardiol 2015;65:76-81.
17. Kellman P, Wilson JR, Xue H, Ugander M, Arai AE. Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson 2012;14:63.
18. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002;47:372-83.
19. Arheden H, Saeed M, Higgins CB, Gao DW, Ursell PC, Bremerich J et al. Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology 2000; 215:520-8.
20. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105:224-9.
21. Arheden H, Saeed M, Higgins CB, Gao DW, Bremerich J, Wyttenbach R et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA auto-radiography in rats. Radiology 1999;211:698-708.
22. Saeed M, Higgins CB, Geschwind JF, Wendland MF. T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging. Eur Radiol 2000; 10:310-8.
23. Flacke SJ, Fischer SE, Lorenz CH. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardiuminvivo: normal distribution and elevation in acute and chronic infarction. Radiology 2001;218:703-10.
24. Schaefer S, Malloy CR, Katz J, Parkey RW, Buja LM, Willerson JT et al. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. J Am Coll Cardiol 1988;12: 1064-72.
25. Saeed M, Bremerich J, Wendland MF, Wyttenbach R, Weinmann HJ, Higgins CB. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. Radiology 1999;213:247-57.
26. Ibrahim T, Hackl T, Nekolla SG, Breuer M, Feldmair M, Schomig A et al. Acute myo-cardial infarction: serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion. Radiology 2010; 254:88-97.
27. Engblom H, Hedstrom E, Heiberg E, Wagner GS, Pahlm O, Arheden H. Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: one-year follow-up by MRI. Circ Cardiovasc Imaging 2009;2:47-55.
28. Rogers WJ Jr, Kramer CM, Geskin G, Hu YL, Theobald TM, Vido DA et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocar-dial infarction. Circulation 1999;99:744-50.
29. O'Regan DP, Ariff B, Baksi AJ, Gordon F, Durighel G, Cook SA. Salvage assessment with cardiac MRI following acute myocardial infarction underestimates potential for recovery of systolic strain. Eur Radiol 2013;23:1210-7.
30. Hammer-Hansen S, Ugander M, Hsu LY, Taylor J, Thune JJ, Kober L et al. Distinction of salvaged and infarcted myocardium within the ischaemic area-at-risk with T2 mapping. Eur Heart J Cardiovasc Imaging 2014;15:1048-53.
31. Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson 2014;16:2.
32. Reimer KA, Jennings RB. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979;40:633-44.